<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/Organization>
<http://www.news-medical.net/news/20130411/Pharmacyclics-presents-positive-results-of-ibrutinib-Phase-II-trial-in-untreated-relapsed-and-refractory-CLL-patients.aspx>